Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Treatment Options for Older CLL Pts: BTKi Lead to Impressive PFS, Time-Limited Regimen With Ven–Obinutuzumab, Ibrutinib + Venetoclax Is Effective and Safe
Login to view comments.
Click here to Login
Malignant Hematology